Trending Now
Exelis Inc. (NASDAQ:EXEL) Announce Positive Results Of The COSMIC-021 Study Of...
Exelis Inc. (NASDAQ:EXEL) has announced positive Phase 1b clinical study results for the cabozantinib (CABOMETYX®) and atezolizumab (TECENTRIQ®) combination in treating patients with metastatic/locally...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Vascular Biogenics Ltd (NASDAQ: VBLT) Introduces Additional Endpoint In The Phase...
Vascular Biogenics Ltd (NASDAQ: VBLT) added a second primary objective of PFS (Progression free survival) in its Phase 3 Oval registration enabling trial of...
MAKE IT MODERN
LATEST REVIEWS
Sorrento Therapeutics Inc. (NASDAQ:SRNE) Completes the Acquisition of SmartPharm to Advance...
Since its establishment in 2009, Sorrento Therapeutics Inc. (NASDAQ:SRNE) has had a long journey of discovering diversified therapies for managing cancer and possibly curable...
MAKE IT MODERN
PERFORMANCE TRAINING
Capricor Therapeutics (NASDA: CAPR) Enters Exclusive Agreement with Nippon Shinyaku Co. Ltd. on DMD...
Capricor Therapeutics (NASDA: CAPR) and Nippon Shinyaku Co. Ltd. have signed an exclusive distribution deal for CAP-1002 for Duchenne muscular dystrophy (DMD) treatment in...
B2Digital Inc (OTCMKTS:BTDG) Sets Up for Big Things Ahead
B2Digital Inc (OTCMKTS:BTDG), an emerging force on the OTC billing itself as the premier development league for the UFC and top pro MMA sports,...
It’s Time for Healthcare Stocks 2.0 (TDOC, RXMD, GDRX)
The shift in the healthcare space over the past six months is perhaps the most striking of all for market participants, from a thematic...
AbCellera Biologics Inc (NASDAQ:ABCL) Expands Collaboration Accord With Gilead Sciences, Inc (NASDAQ:GILD) For A...
AbCellera Biologics Inc (NASDAQ:ABCL) signed an extended collaboration deal with Gilead Sciences, Inc (NASDAQ:GILD) for multi-body antibody discovery. The deal also provides access to...
Cytokinetics Incorporated (NASDAQ:CYTK) Announces Its Q3 2020 Results And Progress Of GALACTIC-HF Clinical Study
Cytokinetics Incorporated (NASDAQ:CYTK) has announced its Q3 2020 financial results in which net loss was $3.2 million or $0.05 per share. At the end...
MAKE IT MODERN
